Methylation levels of SLC23A2 and NCOR2 genes correlate with spinal muscular atrophy severity

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Zheleznyakova, Galina Yu ^a,b,c   Nilsson, Emil K ^a   Kiselev, Anton V ^c   Maretina, Marianna A ^b,c   Tishchenko, Lyudmila I ^b   Fredriksson, Robert ^b   Baranov, Vladislav S ^b,c   Schiöth, Helgi B ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^c D O OTT RESEARCH INSTITUTE OF OBSTETRICS   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

5' UNTRANSLATED REGION; ADULT; ARHGAP2 GENE; ARTICLE; CDK2AP1 GENE; CHML GENE; CONTROLLED STUDY; CPG ISLAND; DISEASE SEVERITY; DNA METHYLATION; FEMALE; GENE; GENE DOSAGE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE TARGETING; GENETIC ASSOCIATION; GENOME ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NCOR2 GENE; REGULATORY SEQUENCE; RPL9 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SLC23A2 GENE; SPINAL MUSCULAR ATROPHY; ADOLESCENT; CASE CONTROL STUDY; GENETICS; HEREDITARY SPINAL MUSCULAR ATROPHY; INFANT; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD;

5' UNTRANSLATED REGION; NCOR2 PROTEIN, HUMAN; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; SLC23A2 PROTEIN, HUMAN; SODIUM ASCORBIC ACID COTRANSPORTER;

5' UNTRANSLATED REGIONS; ADOLESCENT; BASE SEQUENCE; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; CPG ISLANDS; DNA METHYLATION; FEMALE; HUMANS; INFANT; MALE; MOLECULAR SEQUENCE DATA; NUCLEAR RECEPTOR CO-REPRESSOR 2; SODIUM-COUPLED VITAMIN C TRANSPORTERS; SPINAL MUSCULAR ATROPHIES OF CHILDHOOD;

EID: 84926377292     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121964     Document Type: Article

References (44)

1. Biros I, Forrest S. Spinal muscular atrophy: untangling the knot? J Med Genet. 1999; 36(1): 1-8. PMID: 9950358
2. Munsat TL, Davies KE. International SMA consortium meeting. (26-28 June 1992, Bonn, Germany). Neuromuscul Disord. 1992; 2(5-6): 423-428. PMID: 1483045
3. Zerres K, Rudnik-Schöneborn S. Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications. Arch Neurol. 1995; 52(5): 518-523. PMID: 7733848
4. Lefebvre S, Bürglen L, Reboullet S, Clermont O, Burlet P, Viollet L, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995; 80(1): 155-165. PMID: 7813012
5. Hua Y, Zhou J. Survival motor neuron protein facilitates assembly of stress granules. FEBS Lett. 2004; 572(1-3): 69-74. PMID: 15304367
6. Briese M, Esmaeili B, Sattelle DB. Is spinal muscular atrophy the result of defects in motor neuron processes? BioEssays News Rev Mol Cell Dev Biol. 2005; 27(9): 946-957.
7. Nölle A, Zeug A, van Bergeijk J, Tönges L, Gerhard R, Brinkmann H, et al. The spinal muscular atrophy disease protein SMN is linked to the Rho-kinase pathway via profilin. Hum Mol Genet. 2011; 20(24): 4865-4878. doi: 10.1093/hmg/ddr425 PMID: 21920940
8. Feldkötter M, Schwarzer V, Wirth R, Wienker TF, Wirth B. Quantitative Analyses of SMN1 and SMN2 Based on Real-Time LightCycler PCR: Fast and Highly Reliable Carrier Testing and Prediction of Severity of Spinal Muscular Atrophy. Am J Hum Genet. 2002; 70(2): 358-368. PMID: 11791208
9. Cuscó I, Barceló MJ, Rojas-García R, Illa I, Gámez J, Cervera C, et al. SMN2 copy number predicts acute or chronic spinal muscular atrophy but does not account for intrafamilial variability in siblings. J Neurol. 2006; 253(1): 21-25. PMID: 15981080
10. Zheleznyakova GY, Kiselev AV, Vakharlovsky VG, Rask-Andersen M, Chavan R, Egorova AA, et al. Genetic and expression studies of SMN2 gene in Russian patients with spinal muscular atrophy type II and III. BMC Med Genet. 2011; 12: 96. Available: http://www.biomedcentral.com/1471-2350/12/96. doi: 10.1186/1471-2350-12-96 PMID: 21762474
11. Oprea GE, Kröber S, McWhorter ML, Rossoll W, Müller S, Krawczak M, et al. Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science. 2008; 320(5875): 524-527. doi: 10.1126/science.1155085 PMID: 18440926
12. Prior TW, Krainer AR, Hua Y, Swoboda KJ, Snyder PC, Bridgeman SJ, et al. A positive modifier of spinal muscular atrophy in the SMN2 gene. Am J Hum Genet. 2009; 85(3): 408-413. doi: 10.1016/j.ajhg.2009.08.002 PMID: 19716110
13. Bowerman M, Anderson CL, Beauvais A, Boyl PP, Witke W, Kothary R. SMN, profilin IIa and plastin 3: a link between the deregulation of actin dynamics and SMA pathogenesis. Mol Cell Neurosci. 2009; 42 (1): 66-74. doi: 10.1016/j.mcn.2009.05.009 PMID: 19497369
14. Fulka H, Mrazek M, Tepla O, Fulka J. DNA methylation pattern in human zygotes and developing embryos. Reprod Camb Engl. 2004; 128(6): 703-708. PMID: 15163223
15. Pendina AA, Efimova OA, Fedorova ID, Leont'eva OA, Shilnikova EM, Lezhnina JG, et al. DNA methylation patterns of metaphase chromosomes in human preimplantation embryos. Cytogenet Genome Res. 2011; 132(1-2): 1-7. doi: 10.1159/000322824 PMID: 21212648
16. Ai S, Shen L, Guo J, Feng X, Tang B. DNA methylation as a biomarker for neuropsychiatric diseases. Int J Neurosci. 2012; 122(4): 165-176. doi: 10.3109/00207454.2011.637654 PMID: 22115417
17. Hauke J, Riessland M, Lunke S, Eyüpoglu IY, Blümcke I, El-Osta A, et al. Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition. Hum Mol Genet. 2009; 18(2): 304-317. doi: 10.1093/hmg/ddn357 PMID: 18971205
18. Zheleznyakova GY, Voisin S, Kiselev AV, Sällman Almén M, Xavier MJ, Maretina MA, et al. Genomewide analysis shows association of epigenetic changes in regulators of Rab and Rho GTPases with spinal muscular atrophy severity. Eur J Hum Genet. 2013; 21(9): 988-993. doi: 10.1038/ejhg.2012.293 PMID: 23299920
19. Seo J, Howell MD, Singh NN, Singh RN. Spinal muscular atrophy: an update on therapeutic progress. Biochim Biophys Acta. 2013; 1832(12): 2180-2190. doi: 10.1016/j.bbadis.2013.08.005 PMID: 23994186
20. Eds. Allis CD, Jenuwein T, Reinberg D, Caparros ML. Epigenetics. 1st ed. New York: Cold Spring Harbor Laboratory Press; 2007.
21. Choi JK, Bae J-B, Lyu J, Kim T-Y, Kim Y-J. Nucleosome deposition and DNA methylation at coding region boundaries. Genome Biol. 2009; 10(9): R89. Available: http://genomebiology.com/2009/10/9/r89 doi: 10.1186/gb-2009-10-9-r89 PMID: 19723310
22. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press; 1989.
23. Rohde C, Zhang Y, Reinhardt R, Jeltsch A. BISMA-Fast and accurate bisulfite sequencing data analysis of individual clones from unique and repetitive sequences. BMC Bioinformatics. 2010; 11(1): 230. Available: http://www.biomedcentral.com/1471-2105/11/230
24. Lewin J, Schmitt AO, Adorján P, Hildmann T, Piepenbrock C. Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinforma Oxf Engl. 2004; 20(17): 3005-3012.
25. Baron U, Türbachova I, Hellwag A, Eckhardt F, Berlin K, Hoffmuller U, et al. DNA methylation analysis as a tool for cell typing. Epigenetics. 2006; 1(1): 55-60. PMID: 17998806
26. Heberlein A, Muschler M, Frieling H, Behr M, Eberlein C, Wilhelm J, et al. Epigenetic down regulation of nerve growth factor during alcohol withdrawal. Addict Biol. 2013; 18(3): 508-510. doi: 10.1111/j.1369-1600.2010.00307.x PMID: 21392176
27. Domschke K, Tidow N, Schrempf M, Schwarte K, Klauke B, Reif A, et al. Epigenetic signature of panic disorder: a role of glutamate decarboxylase 1 (GAD1) DNA hypomethylation? Prog Neuropsychopharmacol Biol Psychiatry. 2013; 46: 189-196. doi: 10.1016/j.pnpbp.2013.07.014 PMID: 23906988
28. Roessler J, Ammerpohl O, Gutwein J, Hasemeier B, Anwar SL, Kreipe H, et al. Quantitative cross-validation and content analysis of the 450k DNA methylation array from Illumina, Inc. BMC Res Notes. 2012; 5: 210. Available: http://www.biomedcentral.com/1756-0500/5/210 doi: 10.1186/1756-0500-5-210 PMID: 22546179
29. Pan H, Chen L, Dogra S, Teh AL, Tan JH, Lim YI, et al. Measuring the methylome in clinical samples: improved processing of the Infinium Human Methylation450 BeadChip Array. Epigenetics. 2012; 7(10): 1173-1187. doi: 10.4161/epi.22102 PMID: 22964528
30. May JM. Vitamin C transport and its role in the central nervous system. Subcell Biochem. 2012; 56: 85-103. doi: 10.1007/978-94-007-2199-9-6 PMID: 22116696
31. Qiao H, May JM. CpG methylation at the USF-binding site mediates cell-specific transcription of human ascorbate transporter SVCT2 exon 1a. Biochem J. 2011; 440(1): 73-84. doi: 10.1042/BJ20110392 PMID: 21770893
32. Mill J, Tang T, Kaminsky Z, Khare T, Yazdanpanah S, Bouchard L, et al. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet. 2008; 82(3): 696-711. doi: 10.1016/j.ajhg.2008.01.008 PMID: 18319075
33. Alrfaei BM, Vemuganti R, Kuo JS. microRNA-100 Targets SMRT/NCOR2, Reduces Proliferation, and Improves Survival in Glioblastoma Animal Models. PLoS ONE. 2013; 8(11): e80865. Available: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0080865 doi: 10.1371/journal.pone. 0080865 PMID: 24244722
34. Spruijt CG, Vermeulen M. DNA methylation: old dog, new tricks? Nature Structural & Molecular Biology. 2014; 21: 949-954.
35. Medvedeva YA, Khamis AM, Kulakovskiy IV, Ba-Alawi W, Bhuyan SMd, Kawaji H, Lassmann T, et al. Effects of cytosine methylation on transcription factor binding sites. BMC Genomics. 2014; 15: 119. Available: http://www.biomedcentral.com/1471-2164/15/119 doi: 10.1186/1471-2164-15-119 PMID: 24669864
36. Jiang Q, Galiègue-Zouitina S, Roumier C, Hildebrand MP, Thomas S, Coignet LJ. Genomic organization and refined mapping of the human nuclear corepressor 2 (NCOR2)/silencing mediator of retinoid and thyroid hormone receptor (SMRT) gene on chromosome 12q24.3. Cytogenet Cell Genet. 2001; 92 (3-4): 217-220.
37. Codina A, Love JD, Li Y, Lazar MA, Neuhaus D, Schwabe JWR. Structural insights into the interaction and activation of histone deacetylase 3 by nuclear receptor corepressors. Proc Natl Acad Sci U S A. 2005; 102(17): 6009-6014. PMID: 15837933
38. Guenther MG, Barak O, Lazar MA. The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol Cell Biol. 2001; 21(18): 6091-6101. PMID: 11509652
39. Zou J, Barahmand-pour F, Blackburn ML, Matsui Y, Chansky HA, Yang L. Survival Motor Neuron (SMN) Protein Interacts with Transcription Corepressor mSin3A. J Biol Chem. 2004; 279(15): 14922-14928. PMID: 14749338
40. Wong DTW, Kim JJ, Khalid O, Sun HH, Kim Y. Double edge: CDK2AP1 in cell-cycle regulation and epigenetic regulation. J Dent Res. 2012; 91(3): 235-241. doi: 10.1177/0022034511420723 PMID: 21865592
41. Darbar IA, Plaggert PG, Resende MBD, Zanoteli E, Reed UC. Evaluation of muscle strength and motor abilities in children with type II and III spinal muscle atrophy treated with valproic acid. BMC Neurol. 2011; 11: 36. Available: http://www.biomedcentral.com/1471-2377/11/36 doi: 10.1186/1471-2377-11-36 PMID: 21435220
42. Baranov VS, Kiselev AV, Vakharlovskii VG, Zhelezniakova GI, Komantsev VN, Malysheva OV, et al. Molecular genetic basis of proximal spinal muscular atrophy and experience in its pharmaceutical treatment. Russian Journal of Genetics. 2008; 44(10): 1148-1159.
43. Mutsaers CA, Wishart TM, Lamont DJ, Riessland M, Schreml J, Comley LH, et al. Reversible molecular pathology of skeletal muscle in spinal muscular atrophy. Hum Mol Genet. 2011; 20(22): 4334-4344. doi: 10.1093/hmg/ddr360 PMID: 21840928
44. Mastroeni D, Grover A, Delvaux E, Whiteside C, Coleman PD, Rogers J. Epigenetic changes in Alzheimer's disease: decrements in DNA methylation. Neurobiol Aging. 2010; 31(12): 2025-2037. doi: 10.1016/j.neurobiolaging.2008.12.005 PMID: 19117641